Making Every Nanoliter Count

Microfluidics, the science that underlies technologies for manipulating minute volumes of liquids, is the new buzzword in biology-and with good reason. Microfluidics has the potential to revolutionize the way routine molecular biology experiments are carried out. This technology is being used to miniaturize biological separation and assay techniques so that entire experiments can be accomplished within diminutive devices that are about as large as a computer chip. Picoliter-to-nanoliter volumes

Written byDeborah Fitzgerald
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

Microfluidic approaches offer several benefits over their standard molecular biology counterparts. The most obvious benefit is decreased sample volume (which results in decreased waste volume), but microfluidic approaches are also economical in the long run. Perhaps even more importantly, miniaturization can result in dramatically increased performance. Microfluidic technologies are highly amenable to automation and offer the potential for the massive, parallel processing of laboratory procedures.

Fluid movement through the tiny vessels of microfluidics devices is fundamentally different from that through their familiar, larger counterparts. Thus, microfluidics researchers must devise ways to exploit the properties that are desirable in a given context, and to circumvent those that are not. For example, fluid flow in microfluidic channels is laminar rather than turbulent; multiple flow streams run side by side, with mixing mediated only by diffusion. This general feature is advantageous in some, but not all, cases, so some designers make adaptations such ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies